TECHNETIUM 99-M- OXYTOCIN AS A NOVEL RADIOPHARMACEUTICAL FOR THE DETECTION OF BREAST CANCER.

摘要

The present invention refers to a novel radiopharmaceutical of Technetium-99m-oxytocin as an agent for the diagnosis of breast cancer by gammagraphic images, which is able to detect in vivo the overexpression of oxytocin receptors in MCF7 cells of human breast cancer. The purpose of the present invention is to provide a novel specific radiopharmaceutical (molecular target radiopharmaceutical) for a diagnosis of breast cancer totally different from those currently available on the market.